Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eide

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Expert Opinion on Investigational Drugs|May 22, 2008
New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in checkThomas O'Hare, Christopher A Eide, Michael W Deininger
Journal of the National Cancer Institute|June 26, 2008
Persistent LYN signaling in imatinib-resistant, BCR-ABL-independent chronic myelogenous leukemiaThomas O'Hare, Christopher A Eide, Michael W Deininger
Clinical Lymphoma & Myeloma|March 27, 2007
Bcr-Abl kinase domain mutations and the unsettled problem of Bcr-AblT315I: looking into the future of controlling drug resistance in chronic myeloid leukemiaThomas O'Hare, Christopher A Eide, Michael W Deininger
Blood|May 15, 2007
Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemiaThomas O'Hare, Christopher A Eide, Michael W N Deininger
Transplantation Proceedings|March 19, 2019
Marine n-3 Polyunsaturated Fatty Acid Supplementation and Quality of Life After Kidney TransplantW Aasebø, M Svensson, T Jenssen, et al.
Transplantation|June 23, 2020
The Authors' Reply: Placental Pathology in Pregnancies After Kidney TransplantationAnupam Chandra, Karsten Midtvedt, Anders Åsberg, et al.
Cancer Cell|April 15, 2020
Response and Resistance to BCR-ABL1-Targeted TherapiesTheodore P Braun, Christopher A Eide, Brian J Druker
Acta Ophthalmologica|March 16, 2023
Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohortTrude E Robsahm, Ragnhild S Falk, Nils A Eide
Clinical Lymphoma & Myeloma|March 4, 2009
New strategies for the first-line treatment of chronic myeloid leukemia: can resistance be avoided?Jennifer L Snead, Thomas O'Hare, Christopher A Eide, et al.
Case Reports in Oncology|October 30, 2024
Delayed Distant Recurrence of a Uveal Melanoma 4 Decades after EnucleationNils A Eide, Agate Noer, Henrik Jespersen, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|May 22, 2008
New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in checkThomas O'Hare, Christopher A Eide, Michael W Deininger
Journal of the National Cancer Institute|June 26, 2008
Persistent LYN signaling in imatinib-resistant, BCR-ABL-independent chronic myelogenous leukemiaThomas O'Hare, Christopher A Eide, Michael W Deininger
Clinical Lymphoma & Myeloma|March 27, 2007
Bcr-Abl kinase domain mutations and the unsettled problem of Bcr-AblT315I: looking into the future of controlling drug resistance in chronic myeloid leukemiaThomas O'Hare, Christopher A Eide, Michael W Deininger
Blood|May 15, 2007
Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemiaThomas O'Hare, Christopher A Eide, Michael W N Deininger
Transplantation Proceedings|March 19, 2019
Marine n-3 Polyunsaturated Fatty Acid Supplementation and Quality of Life After Kidney TransplantW Aasebø, M Svensson, T Jenssen, et al.
Transplantation|June 23, 2020
The Authors' Reply: Placental Pathology in Pregnancies After Kidney TransplantationAnupam Chandra, Karsten Midtvedt, Anders Åsberg, et al.
Cancer Cell|April 15, 2020
Response and Resistance to BCR-ABL1-Targeted TherapiesTheodore P Braun, Christopher A Eide, Brian J Druker
Acta Ophthalmologica|March 16, 2023
Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohortTrude E Robsahm, Ragnhild S Falk, Nils A Eide
Clinical Lymphoma & Myeloma|March 4, 2009
New strategies for the first-line treatment of chronic myeloid leukemia: can resistance be avoided?Jennifer L Snead, Thomas O'Hare, Christopher A Eide, et al.
Case Reports in Oncology|October 30, 2024
Delayed Distant Recurrence of a Uveal Melanoma 4 Decades after EnucleationNils A Eide, Agate Noer, Henrik Jespersen, et al.
Pageof 15